[ Price : $8.95]
A report on the 2024 Global Summit on Regulatory Science calls for a collaborative global effort to harness artificial intelligenc...[ Price : $8.95]
Three FDA staffers discuss the agencys efforts to advance the use of digital health technologies in clinical trials.[ Price : $8.95]
Recent FDA layoffs raise concerns across the drug and biologic industries as experts warn that diminished inspection capacity coul...[ Price : $8.95]
FDA warns Downey, CA-based Naturista Store that it is marketing an unapproved, misbranded drug as a dietary supplement that contai...[ Price : $8.95]
FDA warns Clarence, NY-based PMS4PMS that it is illegally marketing a misbranded over-the-counter menstrual cream that is manufact...[ Price : $8.95]
FDA clears a Phase 1 human trial of an eGenesis porcine liver for use with an OrganOx system for perfusion of intensive care patie...[ Price : $8.95]
Sanofi says data from a Phase 2 study of amlitelimab misses its endpoint in adults with moderate-to-severe asthma, while promising...[ Price : $8.95]
Mural Oncology discontinues all clinical development of its lead drug candidate, nemvaleukin alfa based on disappointing results f...